A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients

References

• Dansk Lunge Cancer Gruppe & Dansk Lunge Cancer Register, Årsrapport 2007.
   Google Scholar
• Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi AT, . Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999;24:31–7.
   PubMed Web of Science ®Google Scholar
• Mehta M, Manon R. Are more aggressive therapies able to improve treatment of locally advanced non-small cell lung cancer: Combined modality treatment? Semin Oncol 2005;32:S25–34.
   PubMed Web of Science ®Google Scholar
• Kong FM, Haken RKT, Schipper MJ, Sullivan MA, Chen M, Lopez C, . High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:324–33.
   PubMed Web of Science ®Google Scholar
• Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23–33.
   PubMed Web of Science ®Google Scholar
• Fenwick JD, Nahum AE, Malik ZI, Eswar CV, Hatton MQ, Laurence VM, . Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: Opportunities for treatment improvement. Clin Oncol 2009;21: 343–60.
   Web of Science ®Google Scholar
• Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, . Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 2004;73: 285–7.
   PubMed Web of Science ®Google Scholar
• Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon JV, Houben R, . Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 2009;91:386–92.
   PubMed Web of Science ®Google Scholar
• Manus MPM, Hicks RJ, Matthews JP, Wirth A, Rischin D, Ball DL. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 2005;49: 95–108.
   PubMed Web of Science ®Google Scholar
• Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, . Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61:318–28.
   PubMed Web of Science ®Google Scholar
• Van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans A-MC, . Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J Clin Oncol 2010;28:1380–6.
   PubMed Web of Science ®Google Scholar
• St-Hilaire J, Sévigny C, Beaulieu F, Germain F, Lavoie C, Dagnault A, . Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients. Radiother Oncol 2009;91:342–8.
   PubMed Web of Science ®Google Scholar
• Tanoue LT, Detterbeck FC. New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther 2009;9:413–23.
   PubMed Web of Science ®Google Scholar
• Wolthaus JWH, Schneider C, Sonke J-J, van Herk M, Belderbos JSA, Rossi MMG, . Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys 2006;65:1560–71.
   PubMed Web of Science ®Google Scholar
• Prescribing, recording, and reporting intensity-modulated photon-beam therapy. J ICRU 2010 Report No. 83;10.
   Google Scholar
• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, . Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109–22.
   PubMed Web of Science ®Google Scholar
• Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, . Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76:S70–6.
   PubMed Web of Science ®Google Scholar
• Adkison JB, Khuntia D, Bentzen SM, Cannon GM, Tome WA, Jaradat H, . Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat 2008;7:441–7.
   PubMed Web of Science ®Google Scholar
• Koukourakis M, Hlouverakis G, Kosma L, Skarlatos J, Damilakis J, Giatromanolaki A, . The impact of overall treatment time on the results of radiotherapy for non small cell lung carcinoma. Int J Radiat Oncol Biol Phys 1996;34:315–22.
   PubMed Web of Science ®Google Scholar
• Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients. Acta Oncol 2010;49:1077–84.
   PubMed Web of Science ®Google Scholar
• MacManus M, Nestle U, Rosenzweig KE, Carrio I, Messa C, Belohlavek O, . Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiother Oncol 2009;91:85–94.
   PubMed Web of Science ®Google Scholar
• Aerts HJWL, Bosmans G, van Baardwijk AAW, Dekker ALAJ, Oellers MC, Lambin P, . Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: A prospective study: Int J Radiat Oncol Biol Phys 2008;71:1402–7.
   PubMed Web of Science ®Google Scholar
• Sura S, Greco C, Gelblum D, Yorke ED, Jackson A, Rosenzweig KE. (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1397–402.
   PubMed Web of Science ®Google Scholar
• Aerts HJWL, Lambin P, Ruysscher DD. FDG for dose painting: A rational choice. Radiother Oncol 2010;97:163–4.
   PubMed Web of Science ®Google Scholar
• Partridge M, Yamamoto T, Grau C, Høyer M, Muren LP. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol 2010;49:997–1011.
   PubMed Web of Science ®Google Scholar
• Nyeng TB, Kallehauge JF, Høyer M, Petersen JBB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol (in press).
   Web of Science ®Google Scholar